BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 4, 2008
View Archived Issues
ASIC1a a potential target for reducing seizures
Read More
Snapshots of alogliptin studies
Read More
TRU-015 shows good pharmacokinetic profile and safety in rheumatoid arthritis patients
Read More
Celera completes separation from Applera
Read More
CoLucid closes series B financing to fund development of COL-144
Read More
FDA approves Promus everolimus-eluting coronary stent system
Read More
Recent Boehringer Ingelheim and University of Minnesota patents report novel anti-HIV agents
Read More
Phase II trial for Fibrin Pad in surgery with severe bleeding begins
Read More
Sinovac begins enrollment in phase II study of pandemic H5N1 influenza vaccine
Read More
TAP merges with Takeda
Read More
CHMP requests additional data analyses from phase III INT-0133 trial of IDM's mifamurtide
Read More
SuperGen comments on results from phase III trial comparing Dacogen to BSC in MDS
Read More
Sciele enters agreement with Addrenex to develop and market ADX-415 for hypertension
Read More
Recent patents cover novel anticancer agents
Read More
United Therapeutics submits NDA to FDA for inhaled formulation of treprostinil for PAH
Read More
CHMP adopts negative opinion for Howmedica's Opgenra
Read More
New therapeutic options for cardiovascular disorders claimed in recent patents
Read More
XL-228 well tolerated in drug-resistant Philadelphia chromosome-positive leukemias
Read More
VG-101 gel, safe and effective in mouse model of vaginal atrophy
Read More
Taisho enters basic business alliance agreement with Biofermin
Read More
Spheramine fails to meet endpoints in phase IIb STEPS trial in PD
Read More
AstraZeneca and Palatin amend January 2007 collaboration agreement in obesity
Read More
Elixir enters license agreement with Boston University for SIRT1 modulators
Read More
Bavituximab achieves primary endpoint in ongoing phase II breast cancer trial
Read More
OncoGenex to independently develop lead cancer drug OGX-011
Read More
Favorable cardiovascular safety study results reported for ARYx's ATI-7505
Read More